NCT04312880View on ClinicalTrials.gov

Tranexamic Acid Infusion During Elective Spine Surgery

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Spine Surgery
Interventions
DRUG

Tranexamic Acid

IV and topical form of TXA will be administered to patients in the respective groups.

Trial Locations (1)

12208

Albany Medical Center, Albany

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER

NCT04312880 - Tranexamic Acid Infusion During Elective Spine Surgery | Biotech Hunter | Biotech Hunter